An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
Børs og finans

Hamstrer biotek-aksjer

Foto: Biotec Pharmacon

Foto: Biotec Pharmacon

Artikkel av: Siri Knutsen Vosgraff
18. februar 2019 - 08.00
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.

CSO i Biotec BetaGlucans, Rolf E. Engstad, har kjøpt 30.400 aksjer i Biotec Pharmacon, opplyses det i en børsmelding.

Aksjene ble kjøpt til en kurs på 4,17 kroner per aksje.

Etter transaksjonen eier Engstad totalt 581.174 aksjer og 40.000 opsjoner i Biotec Pharmacon.

Les hele meldingen her.

An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.
An Error Occurred: Forbidden

Oops! An Error Occurred

The server returned a "403 Forbidden".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.